EcoDrugPlus

Uncharacterized Loc115205958

Ensembl ID : ENSSTUG00000001486
Gene Symbol: LOC115205958
2 Cross references
185 Possible Orthologues:

Urotensin 2 Receptor

Ensembl ID : ENSSTUG00000010528
Gene Symbol: UTS2R
3 Cross references
97 Possible Orthologues:

Utrophin

Ensembl ID : ENSSTUG00000014228
Gene Symbol: UTRN
3 Cross references
263 Possible Orthologues:

Utrophin-Like

Ensembl ID : ENSSTUG00000013735
Gene Symbol: LOC115174451
2 Cross references
264 Possible Orthologues:

Vascular Endothelial Growth Factor A-A

Ensembl ID : ENSSTUG00000047255
Gene Symbol: LOC115177426
3 Cross references
175 Possible Orthologues:

Vascular Endothelial Growth Factor A-A-Like

Ensembl ID : ENSSTUG00000032461
Gene Symbol: LOC115174690
3 Cross references
195 Possible Orthologues:

Vascular Endothelial Growth Factor A-A-Like

Ensembl ID : ENSSTUG00000002031
Gene Symbol: LOC115191647
3 Cross references
195 Possible Orthologues:

Vascular Endothelial Growth Factor A-A-Like

Ensembl ID : ENSSTUG00000046922
Gene Symbol: LOC115175507
3 Cross references
173 Possible Orthologues:

Vasopressin V2 Receptor-Like

Ensembl ID : ENSSTUG00000038695
Gene Symbol: LOC115167817
2 Cross references
172 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSSTUG00000048287
Gene Symbol: VDR
3 Cross references
382 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSSTUG00000041518
Gene Symbol: VDR
3 Cross references
382 Possible Orthologues:

Vitamin D3 Receptor B

Ensembl ID : ENSSTUG00000047493
Gene Symbol: LOC115208313
3 Cross references
385 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).